SLNO
Soleno Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%Jun 30, 2026, 00:00 UTC
Matthew Pauls was appointed as a Class I director of Palvella Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
Jun 30, 2026, 00:00 UTC